Literature DB >> 2753231

Characterization and estrogen regulation of growth factor activity from uterus.

C A Beck1, C W Garner.   

Abstract

Acid-stable uterine-derived growth factor activity, extracted from uteri of several species (rat, rabbit and bovine), stimulates DNA synthesis as measured by [3H]thymidine incorporation into hamster uterine carcinosarcoma (UCS) cells. A time course of [3H]thymidine incorporation demonstrates maximum incorporation at 24 h. These extracts also stimulate [3H]thymidine incorporation in a variety of other cell types from 17 beta-estradiol (E2) target tissues and non-target tissues. Uterine extracts from E2-treated ovariectomized rats show a 3-fold increase in growth factor activity above control values. Activity is elevated within 18-24 h after estradiol injection and remains elevated wtih subsequent injections. Growth factor activity is acid-stable, heat-labile, reduced by trypsin but not reduced by treatment with dextran-coated charcoal. Gel filtration shows molecular weight (Mr) heterogeneity with activity eluting at Mr of 10,000-30,000. Since uterine extracts can restore in vitro the estrogen-regulated properties of uterine growth observed previously in vivo, it is possible that the substances found in these extracts may be mediators of E2 actions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753231     DOI: 10.1016/0303-7207(89)90085-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  Proliferation and differentiation of mouse uterine epithelial cells in primary serum-free culture: estradiol-17 beta suppresses uterine epithelial proliferation cultured on a basement membrane-like substratum.

Authors:  H Fukamachi; J A McLachlan
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

2.  Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts.

Authors:  A Sourla; M Koutsilieris
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.